Sierra Oncology, Inc.
Methods of Treating Cancer with Chk1 Inhibitors
Last updated:
Abstract:
Disclosed herein are methods of treatment by administering SRA737 as a monotherapy or in a combination therapy that is useful for treating patients with cancer.
Status:
Application
Type:
Utility
Filling date:
26 Mar 2020
Issue date:
16 Jun 2022